This activity was planned with a goal to enable participants to learn best practices when prescribing bempedoic acid to the statin intolerant patient. This activity is part of the Bempedoic Acid: New Evidence Transforming the LDL-C Treatment Landscape grant supported by Esperion.
Important Dates: Date of Release: July 30, 2025Term of Approval/Date of Expiration: August 31, 2026 Learner Objective: Upon completion of this activity, you should be able to:
Develop treatment plans tailored to the needs of statin-intolerant patients, leveraging bempedoic acid as a key therapeutic option.
Acknowledgement Educational grant support provided by: Esperion.
Faculty:Erin D. Michos, MD, FACC